Janssen trials ultrasound-guided approach to treating Crohn'...

In the highly competitive market for inflammatory diseases such as Crohn's, pharma companies are looking for ways to maximise benefits of already approved drugs, as well as

J&J strengthens R&D into COVID-19 vaccine with US government

Johnson & Johnson has announced it has expanded a collaboration with a US government agency to hasten development of its coronavirus vaccine, as fears mount about the scale of the outbr

NICE rejects J&J’s Spravato for treatment-resistant depressi...

Janssen's Darzalex approved in EU for newly-diagnosed multip...

Janssen’s Darzalex (daratumumab) has been approved in Europe as a combination therapy in newly-diagnosed patients with multiple myeloma.

J&J to buy US biotech Taris and its bladder cancer drug devi...

Johnson & Johnson is to buy the privately-owned biotech Taris, and a device that can deliver cancer drugs to the bladder.

Merck buys ArQule and BTK drug for $2.7bn

Merck & Co.